2023 Annual Report




March 27, 2024

Annual Report for the year ended 31 December 2023.

The 2023 Annual Report highlights BioCurate’s excellent progress, with milestone success and pipeline growth helping us build a robust portfolio of drug development assets. In particular, the significant growth in our pipeline of early-stage projects was enabled through the expansion of the popular Proof of Concept Scheme with two successful BioCurate Opportunity Application rounds completed, bringing in numerous high-quality opportunities. Pleasingly, all existing Portfolio Projects met key milestones, enabling them to advance to the next stage of development.

BioCurate 2023 Annual Report


Return to News